Sublingual vaccination with outer membrane protein of Porphyromonas gingivalis and Flt3 ligand elicits protective immunity in the oral cavity

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 937-941

  Zhang, Tao ^a,b   Hashizume, Tomomi ^a   Kurita Ochiai, Tomoko ^a   Yamamoto, Masafumi ^a  

^a NIHON UNIVERSITY   (Japan)

^b TIANJIN STOMATOLOGICAL HOSPITAL   (China)

Author keywords

Chronic periodontitis; Flt3 ligand; Outer membrane protein; Porphyromonas gingivalis; Sublingual immunization

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CD8ALPHA ANTIGEN; CHOLERA TOXIN; COMPLEMENTARY DNA; FLT3 LIGAND; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN FLT3 LIGAND CONJUGATE; PLASMID VECTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNITY; LYMPH NODE; MOLECULAR WEIGHT; MOUSE; MOUTH INFECTION; NONHUMAN; OSTEOLYSIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; SPLEEN; SUBMANDIBULAR GLAND; UPREGULATION; VACCINATION;

ADMINISTRATION, SUBLINGUAL; ALVEOLAR BONE LOSS; ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTEROIDACEAE INFECTIONS; CHRONIC PERIODONTITIS; FEMALE; GENETIC VECTORS; IMMUNOGLOBULIN G; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MOUTH; PORPHYROMONAS GINGIVALIS; VACCINATION;

MUS; PORPHYROMONAS GINGIVALIS;

EID: 70449704012     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.081     Document Type: Article

References (30)

1. Cutler C.W., Kalmar J.R., and Genco C.A. Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis. Trends Microbiol. 3 (1995) 45-51
2. Meyer D.H., and Fives-Taylor P.M. Oral pathogens: from dental plaque to cardiac disease. Curr. Opin. Microbiol. 1 (1998) 88-95
3. Beck J., Garcia R., Heiss G., Vokonas P.S., and Offenbacher S. Periodontal disease and cardiovascular disease. J. Periodontol. 67 (1996) 1123-1137
4. Li L., Messas E., Batista Jr. E.L., Levine R.A., and Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 105 (2002) 861-867
5. Hiratsuka K., Abiko Y., Hayakawa M., Ito T., Sasahara H., and Takiguchi H. Role of Porphyromonas gingivalis 40-kDa outer membrane protein in the aggregation of P. gingivalis vesicles and Actinomyces viscosus. Arch. Oral Biol. 37 (1992) 717-724
6. Shibata Y., Hosogi Y., Hayakawa M., Hori N., Kamada M., and Abiko Y. Construction of novel human monoclonal antibodies neutralizing Porphyromonas gingivalis hemagglutination activity using transgenic mice expressing human Ig loci. Vaccine 23 (2005) 3850-3856
7. Momoi F., Hashizume T., Kurita-Ochiai T., Yuki Y., Kiyono H., and Yamamoto M. Nasal vaccination with the 40-kilodalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chimeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies. Infect. Immun. 76 (2008) 2777-2784
8. Koizumi Y., Kurita-Ochiai T., Oguchi S., and Yamamoto M. Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice. Infect. Immun. 76 (2008) 2958-2965
9. Zhang H., Zhang J., and Streisand J.B. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin. Pharmacokinet. 41 (2002) 661-680
10. Kildsgaard J., Brimnes J., Jacobi H., and Lund K. Sublingual immunotherapy in sensitized mice. Ann. Allergy Asthma Immunol. 98 (2007) 366-372
11. Cuburu N., Kweon M.N., Song J.H., Hervouet C., Luci C., Sun J.B., Hofman P., Holmgren J., Anjuere F., and Czerkinsky C. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine 25 (2007) 8598-8610
12. Song J.H., Kim J.I., Kwon H.J., Shim D.H., Parajuli N., Cuburu N., Czerkinsky C., and Kweon M.N. CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination. J. Immunol. 182 (2009) 6851-6860
13. Song J.H., Nguyen H.H., Cuburu N., Horimoto T., Ko S.Y., Park S.H., Czerkinsky C., and Kweon M.N. Sublingual vaccination with influenza virus protects mice against lethal viral infection. Proc. Natl. Acad. Sci. USA 105 (2008) 1644-1649
14. Holmgren J., Czerkinsky C., Eriksson K., and Mharandi A. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine 21 Suppl. 2 (2003) S89-S95
15. Spangler B.D. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56 (1992) 622-647
16. Yamamoto M., McGhee J.R., Hagiwara Y., Otake S., and Kiyono H. Genetically manipulated bacterial toxin as a new generation mucosal adjuvant. Scand. J. Immunol. 53 (2001) 211-217
17. Hunte B.E., Hudak S., Campbell D., Xu Y., and Rennick D. Flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors. J. Immunol. 156 (1996) 489-496
18. Pulendran B., Smith J.L., Caspary G., Brasel K., Pettit D., Maraskovsky E., and Maliszewski C.R. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96 (1999) 1036-1041
19. + dendritic cells for enhanced mucosal immunity. J. Immunol. 172 (2004) 3612-3619
20. Kawamoto Y., Hayakawa M., and Abiko Y. Purification and immunochemical characterization of a recombinant outer membrane protein from Bacteroides gingivalis. Int. J. Biochem. 23 (1991) 1053-1061
21. Maeba S., Otake S., Namikoshi J., Shibata Y., Hayakawa M., Abiko Y., and Yamamoto M. Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit coaggregation by P. gingivalis. Vaccine 23 (2005) 2513-2521
22. Hashizume T., Togawa A., Nochi T., Igarashi O., Kweon M.N., Kiyono H., and Yamamoto M. Peyer's patches are required for intestinal immunoglobulin A responses to Salmonella spp. Infect. Immun. 76 (2008) 927-934
23. Jang M.H., Sougawa N., Tanaka T., Hirata T., Hiroi T., Tohya K., Guo Z., Umemoto E., Ebisuno Y., Yang B.G., Seoh J.Y., Lipp M., Kiyono H., and Miyasaka M. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J. Immunol. 176 (2006) 803-810
24. Blin N., and Stafford D.W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 3 (1976) 2303-2308
25. Baker P.J., Evans R.T., and Roopenian D.C. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch. Oral Biol. 39 (1994) 1035-1040
26. Klausen B., Evans R.T., and Sfintescu C. Two complementary methods of assessing periodontal bone level in rats. Scand. J. Dent. Res. 97 (1989) 494-499
27. Lemiale F., Kong W.P., Akyurek L.M., Ling X., Huang Y., Chakrabarti B.K., Eckhaus M., and Nabel G.J. Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system. J. Virol. 77 (2003) 10078-10087
28. van Ginkel F.W., Jackson R.J., Yuki Y., and McGhee J.R. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J. Immunol. 165 (2000) 4778-4782
29. Mutsch M., Zhou W., Rhodes P., Bopp M., Chen R.T., Linder T., Spyr C., and Steffen R. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N. Engl. J. Med. 350 (2004) 896-903
30. Boonstra A., Asselin-Paturel C., Gilliet M., Crain C., Trinchieri G., Liu Y.J., and O'Garra A. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J. Exp. Med. 197 (2003) 101-109